Eventide Asset Management’s ESSA Pharma EPIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-1,561,251
| Closed | -$2.84M | – | 149 |
|
2022
Q3 | $2.84M | Sell |
1,561,251
-1,804,317
| -54% | -$3.28M | 0.06% | 131 |
|
2022
Q2 | $10.6M | Sell |
3,365,568
-804,691
| -19% | -$2.53M | 0.23% | 96 |
|
2022
Q1 | $25.8M | Buy |
4,170,259
+851,612
| +26% | +$5.26M | 0.4% | 75 |
|
2021
Q4 | $47.1M | Buy |
3,318,647
+1,137,546
| +52% | +$16.2M | 0.6% | 56 |
|
2021
Q3 | $17.4M | Sell |
2,181,101
-224,068
| -9% | -$1.79M | 0.23% | 104 |
|
2021
Q2 | $68.7M | Hold |
2,405,169
| – | – | 0.92% | 40 |
|
2021
Q1 | $69.9M | Buy |
2,405,169
+70,000
| +3% | +$2.03M | 1.04% | 35 |
|
2020
Q4 | $26.5M | Hold |
2,335,169
| – | – | 0.41% | 76 |
|
2020
Q3 | $15.3M | Buy |
2,335,169
+325,000
| +16% | +$2.13M | 0.3% | 90 |
|
2020
Q2 | $11.8M | Hold |
2,010,169
| – | – | 0.26% | 88 |
|
2020
Q1 | $7.64M | Hold |
2,010,169
| – | – | 0.25% | 89 |
|
2019
Q4 | $10.5M | Hold |
2,010,169
| – | – | 0.3% | 78 |
|
2019
Q3 | $6.44M | Buy |
2,010,169
+625,000
| +45% | +$2M | 0.21% | 82 |
|
2019
Q2 | $3.22M | Buy |
1,385,169
+903,198
| +187% | +$2.1M | 0.1% | 91 |
|
2019
Q1 | $1.65M | Buy |
481,971
+1
| +0% | +$3 | 0.06% | 107 |
|
2018
Q4 | $1.01M | Hold |
481,970
| – | – | 0.04% | 117 |
|
2018
Q3 | $1.49M | Sell |
481,970
-1
| -0% | -$3 | 0.05% | 126 |
|
2018
Q2 | $1.82M | Hold |
481,971
| – | – | 0.08% | 117 |
|
2018
Q1 | $1.83M | Buy |
481,971
+346,000
| +254% | +$1.31M | 0.09% | 116 |
|
2017
Q4 | $576K | Hold |
135,971
| – | – | 0.03% | 135 |
|
2017
Q3 | $699K | Hold |
135,971
| – | – | 0.04% | 126 |
|
2017
Q2 | $1.31M | Hold |
135,971
| – | – | 0.08% | 109 |
|
2017
Q1 | $7.41M | Hold |
135,971
| – | – | 0.49% | 57 |
|
2016
Q4 | $5.27M | Hold |
135,971
| – | – | 0.34% | 69 |
|
2016
Q3 | $6.83M | Hold |
135,971
| – | – | 0.42% | 64 |
|
2016
Q2 | $7.37M | Hold |
135,971
| – | – | 0.45% | 62 |
|
2016
Q1 | $7.83M | Buy |
+135,971
| New | +$7.83M | 0.44% | 62 |
|